Inhaler reminders improve adherence with controller treatment in primary care patients with asthma.

BACKGROUND Poor adherence contributes to uncontrolled asthma. Pragmatic adherence interventions for primary care settings are lacking. OBJECTIVE To test the effectiveness of 2 brief general practitioner (GP)-delivered interventions for improving adherence and asthma control. METHODS In a 6-month cluster randomized 2 × 2 factorial controlled trial, with GP as unit of cluster, we compared inhaler reminders and feedback (IRF) and/or personalized adherence discussions (PADs) with active usual care alone; all GPs received action plan and inhaler technique training. GPs enrolled patients prescribed combination controller inhalers, with suboptimal Asthma Control Test (ACT) scores (ACT score ≤19). Inhaler monitors recorded fluticasone propionate/salmeterol adherence (covertly for non-IRF groups) and, in IRF groups, provided twice-daily reminders for missed doses, and adherence feedback. PAD GPs received communication training regarding adherence. Outcomes collected every 2 months included ACT scores (primary outcome) and severe exacerbations. Intention-to-treat mixed-model analysis incorporated cluster effect and repeated measures. RESULTS A total of 43 GPs enrolled 143 patients with moderate-severe asthma (mean age, 40.3 ± 15.2 years; ACT score, 14.6 ± 3.8; fluticasone propionate dose, 718 ± 470 μg). Over 6 months, adherence was significantly higher in the IRF group than in non-IRF groups (73% ± 26% vs 46% ± 28% of prescribed daily doses; P < .0001), but not between PAD and non-PAD groups. Asthma control improved overall (mean change in ACT score, 4.5 ± 4.9; P < .0001), with no significant difference among groups (P = .14). Severe exacerbations were experienced by 11% of the patients in IRF groups and 28% of the patients in non-IRF groups (P = .013; after adjustment for exacerbation history; P = .06). CONCLUSIONS Inhaler reminders offer an effective strategy for improving adherence in primary care compared with a behavioral intervention or usual care, although this may not be reflected in differences in day-to-day asthma control.

[1]  J. Ockene,et al.  Brief physician and nurse practitioner-delivered counseling for high-risk drinking , 2007, Journal of General Internal Medicine.

[2]  K. Resnicow,et al.  Using motivational interviewing to promote adherence to antiretroviral medications: A randomized controlled study , 2008, AIDS care.

[3]  K. Chung,et al.  Difficult-to-Treat Severe Asthma , 2011 .

[4]  Sally E Wenzel,et al.  Recent asthma exacerbations: a key predictor of future exacerbations. , 2007, Respiratory medicine.

[5]  D. Postma,et al.  Integrating real-life studies in the global therapeutic research framework. , 2013, The Lancet. Respiratory medicine.

[6]  M. Pladevall,et al.  A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. , 2010, The Journal of allergy and clinical immunology.

[7]  S. Hahn,et al.  Methodological bias in cluster randomised trials , 2005, BMC medical research methodology.

[8]  Rafael Perera,et al.  Reminder packaging for improving adherence to self-administered long-term medications. , 2011, The Cochrane database of systematic reviews.

[9]  R. Pauwels,et al.  Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. , 2004, American journal of respiratory and critical care medicine.

[10]  M. Kosinski,et al.  Reliability and predictive validity of the Asthma Control Test administered by telephone calls using speech recognition technology. , 2007, The Journal of allergy and clinical immunology.

[11]  S. Bosnic-Anticevich,et al.  The contribution of goal specificity to goal achievement in collaborative goal setting for the management of asthma. , 2013, Research in social & administrative pharmacy : RSAP.

[12]  Christine C Johnson,et al.  Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. , 2004, The Journal of allergy and clinical immunology.

[13]  M. Bachmann,et al.  Motivational consulting versus brief advice for smokers in general practice: a randomized trial , 1999 .

[14]  Steven R Feldman,et al.  The effect of reminder systems on patients’ adherence to treatment , 2012, Patient preference and adherence.

[15]  G. Marks,et al.  Asthma in Australia 2011 , 2011 .

[16]  G. McCarthy,et al.  Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. , 2007, International journal of nursing studies.

[17]  G. Guyatt,et al.  Development and validation of the Mini Asthma Quality of Life Questionnaire. , 1999, The European respiratory journal.

[18]  P. Correll,et al.  Cost is a major barrier to the use of inhaled corticosteroids for obstructive lung disease , 2009, The Medical journal of Australia.

[19]  Pablo A. Mora,et al.  Factor structure and longitudinal invariance of the Medical Adherence Report Scale-Asthma , 2011, Psychology & health.

[20]  C. Hogan,et al.  Barriers to delivering asthma care: a qualitative study of general practitioners , 2005, The Medical journal of Australia.

[21]  Philip Marcus,et al.  Development of the asthma control test: a survey for assessing asthma control. , 2004, The Journal of allergy and clinical immunology.

[22]  A Bond,et al.  Factors affecting general practitioners' recruitment of patients into a prospective study. , 1993, Family practice.

[23]  Richard Beasley,et al.  An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. , 2007, The Journal of allergy and clinical immunology.

[24]  K Rivet Amico,et al.  An information-motivation-behavioral skills model of adherence to antiretroviral therapy. , 2006, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[25]  A. Edwards,et al.  Training practitioners to deliver opportunistic multiple behaviour change counselling in primary care: a cluster randomised trial , 2013, BMJ.

[26]  C. Rand,et al.  The Reliability and Patient Acceptability of the SmartTrack Device: A New Electronic Monitor and Reminder Device for Metered Dose Inhalers , 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.

[27]  R. Snaith,et al.  The Hospital Anxiety and Depression Scale , 1983 .

[28]  W. Miller,et al.  A SMALL STUDY OF TRAINING IN MOTIVATIONAL INTERVIEWING: DOES ONE WORKSHOP CHANGE CLINICIAN AND CLIENT BEHAVIOR? , 2001 .

[29]  S. Bosnic-Anticevich,et al.  Metered-Dose Inhaler Technique: The Effect of Two Educational Interventions Delivered in Community Pharmacy Over Time , 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.

[30]  M. Kosinski,et al.  Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. , 2006, The Journal of allergy and clinical immunology.

[31]  Mark Kosinski,et al.  The minimally important difference of the Asthma Control Test. , 2009, The Journal of allergy and clinical immunology.

[32]  M. Dimatteo,et al.  Physician Communication and Patient Adherence to Treatment : A Meta-analysis , 2018 .

[33]  D. Stempel,et al.  The Status of Asthma Control and Asthma Prescribing Practices in the United States: Results of a Large Prospective Asthma Control Survey of Primary Care Practices , 2005, The Journal of asthma : official journal of the Association for the Care of Asthma.

[34]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[35]  R. Beasley,et al.  Six-month in vitro validation of a metered-dose inhaler electronic monitoring device: implications for asthma clinical trial use. , 2012, Journal of Allergy and Clinical Immunology.

[36]  L. Boulet,et al.  The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma. , 2005, Clinical therapeutics.

[37]  T. Peters,et al.  GPs' experiences of primary care mental health research: a qualitative study of the barriers to recruitment. , 2007, Family practice.

[38]  S. Bosnic-Anticevich,et al.  Healthcare professional versus patient goal setting in intermittent allergic rhinitis. , 2008, Patient education and counseling.

[39]  A. Herxheimer,et al.  Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. , 2001, BMJ : British Medical Journal.

[40]  G. Piaggio,et al.  Consort 2010 statement: extension to cluster randomised trials , 2012, BMJ : British Medical Journal.

[41]  S. Bosnic-Anticevich,et al.  Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. , 2007, The Journal of allergy and clinical immunology.

[42]  S. Suissa,et al.  Low-dose inhaled corticosteroids and the prevention of death from asthma. , 2000, The New England journal of medicine.

[43]  R B Haynes,et al.  Interventions to enhance medication adherence. , 2005, The Cochrane database of systematic reviews.

[44]  David Moher,et al.  Reporting Methods of Blinding in Randomized Trials Assessing Nonpharmacological Treatments , 2007, PLoS medicine.

[45]  H. Reddel.  Rational prescribing for asthma in adults – written asthma action plans , 2012 .

[46]  L. Boulet,et al.  Treatment adherence and psychosocial factors in severe asthma , 2011 .

[47]  B. Toelle,et al.  Written individualised management plans for asthma in children and adults. , 2011, The Cochrane database of systematic reviews.

[48]  C. Rand,et al.  Identifying patient‐specific beliefs and behaviours for conversations about adherence in asthma , 2012, Internal medicine journal.

[49]  C. Rand,et al.  Corticosteroid use after hospital discharge among high-risk adults with asthma. , 2004, American journal of respiratory and critical care medicine.

[50]  A. Jette,et al.  Training physicians to conduct physical activity counseling. , 1997, Preventive medicine.

[51]  I. Pavord,et al.  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. , 2009, American journal of respiratory and critical care medicine.

[52]  E. Burchard,et al.  Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. , 2011, The Journal of allergy and clinical immunology.

[53]  T. T. Haug,et al.  The validity of the Hospital Anxiety and Depression Scale. An updated literature review. , 2002, Journal of psychosomatic research.